FDA Inspection
Megafine Pharma (P) LimitedMegafine Pharma (P) Limited – FDA Inspection, May 12, 2023
Record Details
This FDA Inspection record concerns Megafine Pharma (P) Limited, with an inspection on May 12, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Abdollah Koolivand
- Lisa L. Flores (Investigator)
- Rafeeq A. Habeeb (FDA Associated Person)
View Company Profile
ID · 893a79ec-a5e0-4761-81fc-eb0afaf7a88c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1207908
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Megafine Pharma (P) Limited
4| Date | Classification | Office | Project area |
|---|---|---|---|
| February 21, 2020 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 15, 2018 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 23, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 13, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Megafine Pharma (P) Limited
- FDA Inspection 1121027 - 2020-02-21
- FDA Inspection 1058583 - 2018-06-15
- FDA Inspection 988000 - 2016-09-23
- FDA Inspection 828506 - 2013-03-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.